Vitamin E and Reduced Alanine Transaminase Level

Doses used in studies

IU/day: 298–1,000 (median 649, IQR 298–1,000) — 1 study

Time to effect

Median: 8.6 weeks · IQR 8.6 weeks–8.6 weeks · Range 8.6 weeks–8.6 weeks — Reported in 1 of 1 study

1 of 1 paper

Vitamin E for people with non-alcoholic fatty liver disease.

2024-10-16
Meta-Analysis · n = 708
The Cochrane database of systematic reviews 2024(10)
- Hongzhu Wen
- Hongyong Deng
- Lili Yang
- Lujin Li
- Jiang Lin
- Peiyong Zheng
- Milica Bjelakovic
- Guang Ji

PubMed: 39412049
DOI: 10.1002/14651858.cd015033.pub2

2 Insights on

Reduced Alanine Transaminase Level

High evidence
Clinical

Vitamin E likely slightly reduces serum alanine transaminase (ALT) (MD -9.29, 95% CI -13.69 to -4.89; 11 trials, 708 participants; moderate certainty evidence)

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 298 IU to 1000 IU/day